GUERRASIO, GIANLUCA
GUERRASIO, GIANLUCA
Drug survival analysis of dupilumab and cyclosporin in patients with atopic dermatitis: a multicentre study
2022 Napolitano, Maddalena; Mariano, Maria; Cristaudo, Antonio; Dastoli, Stefano; Di Guida, Adriana; De Lucia, Mario; Guerrasio, Gianluca; Nisticò, Steven Paul; Passante, Maria; Pigliacelli, Flavia; Fabbrocini, Gabriella; Patruno, Cataldo
Acrodermatitis continua of Hallopeau successfully treated with ixekizumab: A case report
2022 Battista, T.; Guerrasio, G.; De Fata Salvatores, G.; Peduto, T.; Fabbrocini, G.; Di Guida, A.
A case of severe psoriatic arthritis with hands flexion contracture and palmar psoriasis successfully treated with guselkumab
2022 Megna, Matteo; Marano, Laura; Camela, Elisa; Potestio, Luca; Fabbrocini, Gabriella; Scalvenzi, Massimiliano; Guerrasio, Gianluca
Effects of COVID-19 pandemic on malignant melanoma diagnosis
2022 Villani, Alessia; Scalvenzi, Massimiliano; Fabbrocini, Gabriella; Fornaro, Luigi; Guerrasio, Gianluca; Potestio, Luca
Reply to “A case of symmetrical drug‐related intertriginous and flexural exanthema‐like eruption associated with Pfizer COVID ‐19 vaccination” by Manaa et al
2022 Camela, Elisa; Scalvenzi, Massimiliano; Megna, Matteo; Potestio, Luca; Guerrasio, Gianluca; Fornaro, Luigi; Fabbrocini, Gabriella; Costa, Claudia
Reply to "A case of pityriasis lichenoides et varioliformis acuta developed after first dose of Oxford-AstraZeneca COVID-19 vaccine"
2023 Martora, Fabrizio; Fabbrocini, Gabriella; Guerrasio, Gianluca; Potestio, Luca
The impact of COVID-19 pandemic on nonmelanoma skin cancers: report of a Southern Italy referral centre
2022 Ruggiero, Angelo; Martora, Fabrizio; Fornaro, Luigi; Guerrasio, Gianluca; di Vico, Francesca; Fabbrocini, Gabriella; Scalvenzi, Massimiliano; Villani, Alessia
Effectiveness of Brodalumab in Patients with Moderate-to-Severe Plaque Psoriasis Located in Difficult-to-Treat Areas
2023 Cacciapuoti, Sara; Potestio, Luca; Guerrasio, Gianluca; Fabbrocini, Gabriella; Scalvenzi, Massimiliano; Ruggiero, Angelo; Caiazzo, Giuseppina; Megna, Matteo
Reply to ‘New‐onset cutaneous lichen planus triggered by COVID‐19 vaccination’ by Merhy et al
2022 Camela, E.; Guerrasio, G.; Patruno, C.; Scalvenzi, M.; Di Caprio, N.; Fabbrocini, G.; Napolitano, M.
Long-Term Efficacy and Safety of Guselkumab in Psoriasis Patients Who Failed Anti-IL17: A Two-Year Real-Life Study
2024 Megna, Matteo; Ruggiero, Angelo; Martora, Fabrizio; Vallone, Ylenia; Guerrasio, Gianluca; Potestio, Luca
Efficacy and safety of sonidegib for the management of basal cell carcinoma: a drug safety evaluation
2023 Villani, Alessia; Scalvenzi, Massimiliano; Micali, Giuseppe; Lacarrubba, Francesco; Genco, Lucia; Ruggiero, Angelo; Fornaro, Luigi; Guerrasio, Gianluca; Potestio, Luca
| Titolo | Tipologia | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|---|
| Drug survival analysis of dupilumab and cyclosporin in patients with atopic dermatitis: a multicentre study | 1.1 Articolo in rivista | 2022 | Napolitano, Maddalena; Mariano, Maria; Cristaudo, Antonio; Dastoli, Stefano; Di Guida, Adriana; De Lucia, Mario; Guerrasio, Gianluca; Nisticò, Steven Paul; Passante, Maria; Pigliacelli, Flavia; Fabbrocini, Gabriella; Patruno, Cataldo | |
| Acrodermatitis continua of Hallopeau successfully treated with ixekizumab: A case report | 1.1 Articolo in rivista | 2022 | Battista, T.; Guerrasio, G.; De Fata Salvatores, G.; Peduto, T.; Fabbrocini, G.; Di Guida, A. | |
| A case of severe psoriatic arthritis with hands flexion contracture and palmar psoriasis successfully treated with guselkumab | 1.1 Articolo in rivista | 2022 | Megna, Matteo; Marano, Laura; Camela, Elisa; Potestio, Luca; Fabbrocini, Gabriella; Scalvenzi, Massimiliano; Guerrasio, Gianluca | |
| Effects of COVID-19 pandemic on malignant melanoma diagnosis | 1.1 Articolo in rivista | 2022 | Villani, Alessia; Scalvenzi, Massimiliano; Fabbrocini, Gabriella; Fornaro, Luigi; Guerrasio, Gianluca; Potestio, Luca | |
| Reply to “A case of symmetrical drug‐related intertriginous and flexural exanthema‐like eruption associated with Pfizer COVID ‐19 vaccination” by Manaa et al | 1.7 Commento, erratum, replica e simili | 2022 | Camela, Elisa; Scalvenzi, Massimiliano; Megna, Matteo; Potestio, Luca; Guerrasio, Gianluca; Fornaro, Luigi; Fabbrocini, Gabriella; Costa, Claudia | |
| Reply to "A case of pityriasis lichenoides et varioliformis acuta developed after first dose of Oxford-AstraZeneca COVID-19 vaccine" | 1.7 Commento, erratum, replica e simili | 2023 | Martora, Fabrizio; Fabbrocini, Gabriella; Guerrasio, Gianluca; Potestio, Luca | |
| The impact of COVID-19 pandemic on nonmelanoma skin cancers: report of a Southern Italy referral centre | 1.1 Articolo in rivista | 2022 | Ruggiero, Angelo; Martora, Fabrizio; Fornaro, Luigi; Guerrasio, Gianluca; di Vico, Francesca; Fabbrocini, Gabriella; Scalvenzi, Massimiliano; Villani, Alessia | |
| Effectiveness of Brodalumab in Patients with Moderate-to-Severe Plaque Psoriasis Located in Difficult-to-Treat Areas | 1.1 Articolo in rivista | 2023 | Cacciapuoti, Sara; Potestio, Luca; Guerrasio, Gianluca; Fabbrocini, Gabriella; Scalvenzi, Massimiliano; Ruggiero, Angelo; Caiazzo, Giuseppina; Megna, Matteo | |
| Reply to ‘New‐onset cutaneous lichen planus triggered by COVID‐19 vaccination’ by Merhy et al | 1.7 Commento, erratum, replica e simili | 2022 | Camela, E.; Guerrasio, G.; Patruno, C.; Scalvenzi, M.; Di Caprio, N.; Fabbrocini, G.; Napolitano, M. | |
| Long-Term Efficacy and Safety of Guselkumab in Psoriasis Patients Who Failed Anti-IL17: A Two-Year Real-Life Study | 1.1 Articolo in rivista | 2024 | Megna, Matteo; Ruggiero, Angelo; Martora, Fabrizio; Vallone, Ylenia; Guerrasio, Gianluca; Potestio, Luca | |
| Efficacy and safety of sonidegib for the management of basal cell carcinoma: a drug safety evaluation | 1.1 Articolo in rivista | 2023 | Villani, Alessia; Scalvenzi, Massimiliano; Micali, Giuseppe; Lacarrubba, Francesco; Genco, Lucia; Ruggiero, Angelo; Fornaro, Luigi; Guerrasio, Gianluca; Potestio, Luca |